Hermosilla, Zaiton S.
HRN: 25-20-01 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/04/2024
CEFUROXIME 1.5GM (VIAL)
06/04/2024
06/05/2024
IV
1.5g
Q8
CS
Waiting Final Action
06/05/2024
CEFUROXIME 500MG (TAB)
06/05/2024
06/11/2024
PO
500mg
BID
CS
Waiting Final Action